The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
Invesco Biotechnology & Genome ETF PBE ETF Analysis
Morningstar’s Analysis PBE
Will PBE outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar